KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) Return on Sales (2016 - 2025)

Teladoc Health's Return on Sales history spans 12 years, with the latest figure at 0.04% for Q4 2025.

  • For Q4 2025, Return on Sales rose 4.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.08%, up 31.0%, while the annual FY2025 figure was 0.08%, 31.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.04% at Teladoc Health, up from 0.08% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.02% in Q4 2021 and bottomed at 11.81% in Q1 2022.
  • The 5-year median for Return on Sales is 0.12% (2023), against an average of 1.31%.
  • The largest annual shift saw Return on Sales crashed -1137bps in 2022 before it soared 1170bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.02% in 2021, then plummeted by -30044bps to 5.97% in 2022, then soared by 99bps to 0.04% in 2023, then crashed by -73bps to 0.08% in 2024, then skyrocketed by 48bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Return on Sales are 0.04% (Q4 2025), 0.08% (Q3 2025), and 0.05% (Q2 2025).